AMD gene therapy (Wellstat Ophthalmics)

N/A

Report date: 2025/01/26 19:14:58

Base Information

Drug NameAMD gene therapy (Wellstat Ophthalmics)
Drug Alias NameAVT-101
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWellstat Therapeutics Corp
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A